After a host of recent advances in the treatment of prostate cancer, the forward push continues as immunotherapy and combinations of older agents are tested in patients.
Prostate Cancer
Latest News
Advertisement
Educated Patient Resource Guide
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Advertisement
The addition of custirsen did not improve survival for a subset of patients with prostate cancer in a phase 3 trial.
Randy F. Sweis talks to CURE about the future of treatment for GU cancers.
CURE spoke with Celestia S. Higano on common problems that survivors of prostate cancer face.
Advertisement
Advertisement
